Biosimilars pipeline report: A guide for understanding the growing market
By AmerisourceBergen
To date, there have been 48 approvals and 38 launches in the U.S. biosimilars market.
Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options. As this market matures, its pipeline continues to grow. This reference guide is a useful tool to visualize and understand the current product landscape and potential future of this emerging market.
We keep this report up to date as the biosimilars market evolves. Enter your information below to receive the newest versions to your inbox as they're released.
Pardot Form
Topics:
Biosimilars
Our role in healthcare